These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 16554872)

  • 21. [Analysis on data from the clinical acute viral encephalitis surveillance system in three prefectures in Shaanxi during 2005 - 2006].
    Zhang SB; Yin ZD; Suraratdecha C; Hills SL; Liu XZ; Li YX; Xia XQ; Liang GD; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):895-8. PubMed ID: 19173854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation into the JE epidemic of 2000 in Upper Assam--a perspective study.
    Kaur R; Agarwal CS; Das D
    J Commun Dis; 2002 Jun; 34(2):135-45. PubMed ID: 14768832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-term study on vector abundance & seasonal prevalence in relation to the occurrence of Japanese encephalitis in Gorakhpur district, Uttar Pradesh.
    Kanojia PC; Shetty PS; Geevarghese G
    Indian J Med Res; 2003 Mar; 117():104-10. PubMed ID: 14575175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
    Turtle L; Brindle HE; Schluter WW; Faragher B; Rayamajhi A; Bohara R; Gurung S; Shakya G; Yoksan S; Dixit S; Rajbhandari R; Paudel B; Adhikari S; Solomon T; Griffiths MJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007269. PubMed ID: 30986252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japanese encephalitis in mainland china.
    Wang H; Li Y; Liang X; Liang G
    Jpn J Infect Dis; 2009 Sep; 62(5):331-6. PubMed ID: 19762980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Japanese encephalitis in two children--United States, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(9):276-8. PubMed ID: 21389931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Japanese encephalitis revisited.
    Diagana M; Preux PM; Dumas M
    J Neurol Sci; 2007 Nov; 262(1-2):165-70. PubMed ID: 17643451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of climatic factors on the distribution and abundance of Japanese encephalitis vectors in Kurnool district of Andhra Pradesh, India.
    Murty US; Rao MS; Arunachalam N
    J Vector Borne Dis; 2010 Mar; 47(1):26-32. PubMed ID: 20231770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatio-temporal epidemiology of Japanese encephalitis in Nepal, 2007-2015.
    Kumar Pant D; Tenzin T; Chand R; Kumar Sharma B; Raj Bist P
    PLoS One; 2017; 12(7):e0180591. PubMed ID: 28746354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An epidemiological review of Japanese encephalitis.
    Okuno T
    World Health Stat Q; 1978; 31(2):120-33. PubMed ID: 214963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecological study on mosquito vectors of Japanese encephalitis virus in Bellary district, Karnataka.
    Kanojia PC
    Indian J Med Res; 2007 Aug; 126(2):152-7. PubMed ID: 17932442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese encephalitis: new options for active immunization.
    Halstead SB; Thomas SJ
    Clin Infect Dis; 2010 Apr; 50(8):1155-64. PubMed ID: 20218889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Japanese encephalitis and Japanese encephalitis virus in mainland China.
    Zheng Y; Li M; Wang H; Liang G
    Rev Med Virol; 2012 Sep; 22(5):301-22. PubMed ID: 22407526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
    Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the distribution of Culex tritaeniorhynchus to predict Japanese encephalitis distribution in the Republic of Korea.
    Masuoka P; Klein TA; Kim HC; Claborn DM; Achee N; Andre R; Chamberlin J; Small J; Anyamba A; Lee DK; Yi SH; Sardelis M; Ju YR; Grieco J
    Geospat Health; 2010 Nov; 5(1):45-57. PubMed ID: 21080320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Japanese encephalitis vaccine in travelers.
    Jelinek T
    Expert Rev Vaccines; 2008 Jul; 7(5):689-93. PubMed ID: 18564023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for Japanese encephalitis: a case-control study.
    Liu W; Gibbons RV; Kari K; Clemens JD; Nisalak A; Marks F; Xu ZY
    Epidemiol Infect; 2010 Sep; 138(9):1292-7. PubMed ID: 20109262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.